Pilot Trial of Telemedicine Evaluation for Stem Cell Transplant Patients
Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Determine patient & physician acceptance of a "virtual medical visit" as a substitute for a "face to face" in pts in different settings. This is assessed by analyzing answers to questions 7 & 8 of the Patient Satisfaction Survey. [Question #7: I would
Question #8: Overall, I was very satisfied with today's telemedicine session.]Physician acceptance will be analyzed looking at the answers to question 19 of the Physician/Nurse survey in which the physician or nurse investigator relates the quality of the telemedicine visit. [Question #19: How would you rate the quality of the Telehealth visit to assess the patient compared to an in-person office visit?]
2 years
No
Sergio Giralt, MD
Principal Investigator
Memorial Sloan-Kettering Cancer Center
United States: Institutional Review Board
11-022
NCT01324427
March 2011
March 2014
Name | Location |
---|---|
Memorial Sloan Kettering Cancer Center | New York, New York 10021 |
Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center | Sleepy Hollow, New York 10591 |
Memoral Sloan Kettering Cancer Center | Basking Ridge, New Jersey |
Memorial Sloan-Kettering Cancer Center @ Suffolk | Commack, New York 11725 |